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Abstract
Background: The study was conducted at a high TB-HIV burden primary health community clinic in Cape Town,
South Africa. We describe the management of children under five years of age in household contact with a smear
and/or culture-positive adult TB case.
Methods: This study was a record review of routinely-collected programme data.
Results: A total of 1094 adult TB case folders were reviewed. From all identified contacts, 149 children should have
received IPT based on local guidelines; in only 2/149 IPT was initiated. Management of child contacts of sputum
smear and/or culture-positive compared to sputum-negative TB patients were similar.
Conclusions: IPT delivery to children remains an operational challenge, especially in high TB-HIV burden
communities. A tool to improve IPT management and targeting sputum smear and/or culture-positive TB child
contacts may overcome some of these challenges and should be developed and piloted in such settings.
Background
South Africa has an estimated tuberculosis (TB) inci-
dence rate ranking first in the world and has one of the
highest reported childhood TB rates [1,2]. The estimated
incidence of childhood TB in the Western Cape Pro-
vince of South Africa was 620/100 000/year in 2007
[unpublished data, Western Cape Department of
Health].
The risk of developing TB in children can be substan-
tially reduced by administration of Isoniazid Preventive
Therapy (IPT) in those infected with Mycobacterium
tuberculosis (M.tb)[3,4]. Children in high TB-burden set-
tings are frequently exposed to cases with infectious TB
at home, leading to infection with M.tb at a young age.
Furthermore, the risk of developing TB is the highest in
children under five years of age [5-7]. Based on the high
risk of disease progression and efficacy of post-exposure
prophylaxis, IPT is therefore recommended by the World
Health Organization (WHO) and South Africa National
TB Programme (SANTP) for all children under five years
of age and all HIV infected children, regardless of age, in
contact with an infectious (smear and/or culture-positive)
TB case [8,9].
Despite these recommendations being in place for
more than 20 years, implementation of IPT in children
appears to be suboptimal in South Africa, where four stu-
dies on IPT delivery in children have been published to
date [10-13]. One hospital-based study from Cape Town,
showed that 117/182 (64.3%) of children admitted with
culture-confirmed TB had missed opportunities for IPT
[10]. Three community-based studies were conducted at
two clinics with annual TB caseloads of 159 and 156
respectively in 2007 [unpublished data, Cape Town City
Health, 2008]; 40% of TB cases received HIV testing of
whom 15% were HIV-positive at these clinics [14]. These
studies showed that fewer than 17% of eligible children
0-5 years initiated IPT and fewer than 15% who initiated
IPT completed 4 months’ therapy [11,13].
Given the increased emphasis on IPT delivery to vul-
nerable populations including children and HIV-infected
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individuals we aimed to investigate health system chal-
lenges in IPT delivery to children in a large TB clinic
with high TB and HIV case loads [15]. The primary
objective was to describe the routine management of
children younger than five years of age in household
contact with a sputum smear and/or culture-positive
adult TB case at a high-burden primary health commu-
nity clinic. A secondary objective was to assess whether
adult sputum smear status was a determinant for IPT
delivery in child contacts.
Methods
Design
This study was a record review of routinely-collected
programme data.
Setting
The study was conducted at a clinic in Khayelitsha, Cape
Town, South Africa, an urban and densely populated
community with a current estimated population of 406
779 [16]. In Khayelitsha 80% of the population live in
informal dwellings, 86% have not completed high school,
47% are unemployed and 55% of households are judged
to be below the poverty line [17]. The TB caseload at the
study clinic was almost 1000 (33% new smear-positive)
patients per annum with a cure rate of 80.5% in new
smear-positive cases in 2007 [unpublished data, Cape
Town City Health, 2008]; 90% of all TB cases routinely
received HIV testing of whom 70% were HIV-positive
[18].
Active contact tracing through home visits by clinic
personnel is not routinely recommended by the SANTP;
rather, guidelines recommend that children under five
years of age who are in close (household) contact with
an adult TB case, should be identified, invited to the
clinic for TB screening and initiate IPT once active TB
disease is excluded. Children in contact with multi-drug
resistant (MDR) TB cases are referred to two off-site
specialized clinics for MDR screening and prophylaxis.
Sample
This study included, as entry point, all adults who
initiated TB treatment during 2008 according to the
electronic TB treatment register (compiled at district
level from paper based TB treatment registers), and all
children younger than five years of age documented to
be in contact with these adult TB cases.
Data collection and outcome measures
An adult TB case was defined as any patient older than
15 years of age who was initiated on anti-tuberculosis
treatment during the defined period. An “infectious” case
was defined as a TB case with either a sputum smear or
culture-positive result. Patients with concurrent
pulmonary and extra-pulmonary disease were defined as
pulmonary. Eligible children were defined as all children
under five years of age reported to be living in the same
household as a sputum smear and/or culture-positive
adult TB case and therefore eligible for IPT, as per
national guidelines. TB screening of the child contact
was defined as any documentation of evaluation for TB,
including clinical evaluation, tuberculin skin testing,
chest radiography and tests of sputum or gastric washing.
A patient folder was defined as absent if it could not be
retrieved from the clinic after two consecutive days of
searching.
Electronic TB registers were used to identify all adult TB
cases diagnosed from January through December 2008.
Using a previously used data extraction tool [13], indivi-
dual TB folders of these adult TB cases were manually
reviewed and contact data extracted. Contact data of eligi-
ble children were then used to identify potential individual
child clinic folders. Using the data extraction tool [13],
information on TB screening and IPT initiation and
adherence were extracted from the child clinic folders.
Due to the different system supporting management of
children in contact with drug-resistant TB cases, these
children were excluded from our study.
Ethics
The protocol was approved by the Ethics Advisory
Group of The Union and the Committee for Human
Research of Stellenbosch University. Cape Town City
Health Directorate gave permission for the study.
Results
From the TB register, 1255 adult TB cases were identi-
fied during the study period. Among these, 1094 indivi-
dual adult TB case folders could be retrieved.
Demographic details of adult TB cases are shown in
Table 1.
From folders that were available for review, a total of
683 (62%) [525 smear-positive and 158 culture-positive]
adults were identified as sputum smear and/or culture-
positive (“infectious”) and 411 (38%) as sputum-nega-
tive/unknown or extra-pulmonary (“non-infectious”).
Three smear-positive adults were MDR TB cases and
therefore excluded from the analyses.
One hundred and forty nine (15%) of all 974 docu-
mented contacts of sputum smear and/or culture-posi-
tive adult TB cases could be identified as being under
five years of age. Only four of these eligible children
were screened for TB, two were initiated on IPT and
one child had documentation of continuation of IPT
and completed three months of treatment according to
the clinic records. Details of contact identification and
management for sputum smear and/or culture-positive
TB cases are provided in figures 1 and 2.
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Fifty six (15%) of the 379 documented contacts of spu-
tum-negative/unknown or extra-pulmonary adult TB
cases could be identified as being under five years of
age. Two of these children who were not eligible for
IPT as per guidelines, were screened for TB and one
was initiated on IPT. None had documentation of conti-
nuation or completion of IPT.
Although formal tests of significance were not com-
pleted due to the small number of children initiated on
IPT, the identification of contacts and documentation of
IPT appeared to be similar for sputum and/or culture-
positive and sputum-negative adult TB cases (Figure 3).
This documentation was also similar for child contacts
of both HIV-positive and negative adults.
Discussion
We report on a large study of programmatic IPT man-
agement in children at a clinic with a high TB and HIV
Table 1 Demographic data of adult TB cases identified from the electronic clinic TB treatment register
Adult TB cases
Total with
individual TB
folder
Sputum
smear
positive
Sputum smear
negative, culture
positive
Sputum smear negative
and culture negative
Sputum
status
unknown
Extra-
pulmonary
No folder
identified
1094 525 (48%) 158 (14%) 152 (14%) 113 (10%) 146 (13%) 160
Age (years)
Med (IQR)
32 (26-41) 31 (25-40) 35 (29-43) 32 (26-41) 34 (28-42) 33 (27-41) 32.5 (28-40)
Male (%) 565 (52) 303 (58) 69 (44) 64 (42) 57 (50) 72 (49) 85 (53)
HIV-infected
(%)
503 (46) 201 (38) 83 (53) 82 (54) 54 (48) 83 (57) 69 (43)
HIV
unknown
(%)
353 (32) 172 (33) 49 (31) 54 (36) 40 (35) 38 (26) 70 (44)
MDR (%) 3 3 0 0 0 0 13 (8)
Retreatment
(%)
296 (27) 135 (26) 62 (39) 38 (25) 34 (30) 27 (18) 58 (36)
 
 
 
 
522 sputum positive TB case folders (excluding 3 MDR TB cases) 
 227 folders: no documentation of contacts 
295 folders had documentation of contacts (783 contacts in total) 
 42 folders: documentation of contact names, but without age (105 contacts) 
 29 folders: documentation of the following: “no contacts < 5yrs” 
 136 folders: documentation of contacts >5yrs (315 contacts) combined with contacts without documentation of age (55 contacts), but 
no contacts < 5yrs 
88 folders had documentation of contacts < 5yrs (112 contacts) combined with contacts >5yrs (165 contacts) and contacts without 
documentation of age (31 contacts) 
 35 folders: documentation of names without surnames (47 contacts < 5yrs of age) 
53 folders had documentation of names and surnames* (65 contacts < 5yrs of age) 
 51 contacts < 5yrs: no individual clinic folders identified 
          14 contacts < 5yrs: individual clinic folders identified 
               3 screened for TB 
1 initiated IPT and completed 3 months of treatment 
*If the surname was not documented, but it was indicated that the child was the son or daughter of the adult TB case, the surname of the adult 
TB case was taken as the surname of the child 
Figure 1 Details of contact identification and management for sputum smear-positive TB cases.
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burden in South Africa. Only 1% (2/149) of children
who could be identified as “eligible” for IPT had any
routine documentation of IPT initiation. Children in
contact with sputum smear and/or culture-positive
adults were not prioritized for prophylaxis, as recom-
mended by WHO [8]. Routine recording of contact
identification and management was neither systematic
nor consistent. At each step along the cascade of IPT
delivery- identification of infectious adult TB cases,
identification of high-risk child contacts, screening for
TB and initiation of IPT - children were missed.
The results of our study revealed considerably worse
IPT delivery to children compared with previous data
from South Africa and other settings [10-13]. In one
South African study, where the same methods were
used, 17% (4/24) of eligible children had documentation
of initiation of IPT [13]. Similarly, in other settings, data
on IPT delivery to children showed IPT initiation rates
of 8% in Malawi [19,20] and 19% in India [21].
Reasons for this poor observed performance have not
yet been fully explored. However, a higher TB clinic
caseload and a higher prevalence of TB-HIV co-infec-
tion, with the concomitantly increased workload on TB
staff, in this study may be a reason for the extremely
poor performance. A simple clinic-based management
tool, such as an IPT register [8], which is linked to the
adult TB register data, may help personnel to prioritise
IPT care for children in contact with sputum smear
and/or culture-positive adults, while spending less time
on children in contact with sputum-negative adults.
Another reason for poor performance may be insuffi-
cient knowledge of contact management amongst health
workers. In a recent Indian study, focus group discus-
sions among health care workers suggested that poor
provision of documentation and a lack of detailed
knowledge about required procedures may be reasons
for poor IPT delivery [21]. Finally, in the face of heavy
demands for care of TB-HIV co-infection, healthcare
workers may not consider IPT particularly important.
Thus, we recommend that knowledge and attitudes
amongst healthcare personnel and parents regarding
IPT delivery should also be investigated.
There are some limitations in this study. We could
only report on routinely-documented data and this may
differ from actual IPT delivery. In addition, it was car-
ried out at a single site and the results may not be
applicable to other similar contexts. Finally, we do not
report on HIV-infected child contacts older than five
years of age.
Conclusions
This study suggests that IPT delivery to children
remains an operational challenge, especially in settings
with a high burden of TB and HIV. A tool to improve
 
 
 
 
158 culture positive TB case folders 
 83 folders: no documentation of contacts 
75 folders had documentation of contacts (191 contacts in total) 
8 folders: documentation of contact names, but without age (18 contacts) 
 9 folders: documentation of the following: “no contacts < 5yrs” 
 29 folders: documentation of contacts >5yrs (69 contacts) combined with contacts without documentation of age (7 contacts), but no 
contacts < 5yrs 
29 folders had documentation of contacts < 5yrs (37 contacts) combined with contacts >5yrs (45 contacts) and contacts without 
documentation of age (15 contacts) 
 9 folders: documentation of names without surnames (11 contacts < 5yrs of age) 
20 folders had documentation of names and surnames* (26 contacts < 5yrs of age) 
 20 contacts < 5yrs: no individual clinic folders identified 
          6 contacts < 5yrs: individual clinic folders identified 
               0 screened for TB 
1 screened for TB and initiated IPT according to individual adult TB folder 
*If the surname was not documented, but it was indicated that the child was the son or daughter of the adult TB case, the surname of the adult 
TB case was taken as the surname of the child 
Figure 2 Details of contact identification and management for sputum smear-negative, culture positive TB cases.
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IPT management and targeting sputum smear and/or
culture-positive TB child contacts may overcome
some of these challenges. Education regarding the
techniques and importance of IPT may also improve
performance.
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